Literature DB >> 22258462

Cardiorenal Syndrome: The Clinical Cardiologists' Perspective.

Eric J Chan, Kevin C Dellsperger.   

Abstract

The term cardiorenal syndrome has evolved over the years. The understanding of the interactions between these two organ systems has led to better recognition and treatment strategies. As cardiovascular mortality is high in individuals with renal dysfunction, it is imperative to understand the pathophysiology behind the disease process. This knowledge may better serve these patients with this syndrome and improve their outcomes. In this review, we examine the key issues of the cardiorenal syndrome from a cardiologist's perspective.
© 2011 S. Karger AG, Basel.

Entities:  

Keywords:  Cardiorenal syndrome; Chronic kidney disease; Coronary artery disease; Heart failure; Metabolic syndrome

Year:  2011        PMID: 22258462      PMCID: PMC3101517          DOI: 10.1159/000322820

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  37 in total

Review 1.  Endothelin antagonists.

Authors:  A Benigni; G Remuzzi
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

2.  Contrast-agent-induced acute renal dysfunction--is iodixanol the answer?

Authors:  Carl M Sandler
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

3.  Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Authors:  Guha Ashrith; Vei-Vei Lee; Macarthur A Elayda; Ross M Reul; James M Wilson
Journal:  Am J Cardiol       Date:  2010-06-18       Impact factor: 2.778

4.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

5.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

6.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors:  W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

7.  Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction.

Authors:  Maria Koreny; Georg Delle Karth; Alexander Geppert; Thomas Neunteufl; Ute Priglinger; Gottfried Heinz; Peter Siostrzonek
Journal:  Am J Med       Date:  2002-02-01       Impact factor: 4.965

8.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

Authors:  Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Craig J Reist; Paul W Armstrong; Kenneth Dickstein; Todd J Lorenz; W Brian Gibler; Vic Hasselblad; Michel Komajda; Barry Massie; John J V McMurray; Markku Nieminen; Jean L Rouleau; Karl Swedberg; Robert M Califf
Journal:  Am Heart J       Date:  2008-12-19       Impact factor: 4.749

Review 9.  Acute decompensated heart failure and the cardiorenal syndrome.

Authors:  Kelly V Liang; Amy W Williams; Eddie L Greene; Margaret M Redfield
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

10.  Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong.

Authors:  Claudio Ronco; Andrew A House; Mikko Haapio
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

View more
  7 in total

Review 1.  Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists.

Authors:  Giorgio Graziani; Daniela Pini; Silvia Oldani; David Cucchiari; Manuel Alfredo Podestà; Salvatore Badalamenti
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

2.  A Common APOE Polymorphism Is an Independent Risk Factor for Reduced Glomerular Filtration Rate in the Spanish RENASTUR Cohort.

Authors:  Eliecer Coto; Juan Gómez; Beatriz Tavira; Salvador Tranche; Francisco Ortega; María I Rodríguez; Emilio Sánchez; Rafael Marín; Ana I Corao; Jorge Arenas; Victoria Alvarez
Journal:  Cardiorenal Med       Date:  2013-05-16       Impact factor: 2.041

3.  HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation.

Authors:  Sumit R Monu; Paola Pesce; Komal Sodhi; Massimo Boldrin; Nitin Puri; Larisa Fedorova; David Sacerdoti; Stephen J Peterson; Nader G Abraham; Attallah Kappas
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

4.  Cardiac Manifestations in Systemic Lupus Erythematosus: A Case Report and Review of the Literature.

Authors:  Alexandra Kreps; Karen Paltoo; Isabel McFarlane
Journal:  Am J Med Case Rep       Date:  2018

Review 5.  OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention.

Authors:  Stephen J Peterson; Abu Choudhary; Amardeep K Kalsi; Shuyang Zhao; Ragin Alex; Nader G Abraham
Journal:  Diagnostics (Basel)       Date:  2020-11-20

Review 6.  HDL Composition, Heart Failure, and Its Comorbidities.

Authors:  Ahmed Diab; Carla Valenzuela Ripoll; Zhen Guo; Ali Javaheri
Journal:  Front Cardiovasc Med       Date:  2022-03-08

7.  Myocardial Stunning with Hemodialysis: Clinical Challenges of the Cardiorenal Patient.

Authors:  Mozow Y Zuidema; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2012-03-30       Impact factor: 2.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.